MURINE BRCA1 - SEQUENCE AND SIGNIFICANCE FOR HUMAN MISSENSE MUTATIONS

被引:51
作者
SHARAN, SK
WIMS, M
BRADLEY, A
机构
[1] BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030
[2] BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030
基金
美国国家卫生研究院;
关键词
D O I
10.1093/hmg/4.12.2275
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have cloned and sequenced a mouse homologue of the human breast and ovarian cancer susceptibility gene, BRCA1. The predicted mouse Brca1 protein is composed of 1812 amino acids, The murine protein is 60% identical and 72% similar to the human BRCA1 protein, Two regions of high homology have been identified between the two proteins. First is the Cys3-His-Cys4 type zinc-finger domain that is identical between the two proteins, The second region is defined by 115 amino acids near the carboxy end of the Brca1 protein that is 83% identical to human BRCA1 sequence. Seven of eight amino acids involved in human missense mutations that are associated with the disease were found to be conserved between the two species, In contrast, most of the amino acids that are involved in polymorphic variations were not conserved. We therefore propose that the interspecies conservation of predicted amino acid sequences can be used as an additional criterion to determine the significance of human missense mutations.
引用
收藏
页码:2275 / 2278
页数:4
相关论文
共 14 条
  • [1] MOUSE NEUROFIBROMATOSIS TYPE-1 CDNA SEQUENCE REVEALS HIGH-DEGREE OF CONSERVATION OF BOTH CODING AND NONCODING MESSENGER-RNA SEGMENTS
    BERNARDS, A
    SNIJDERS, AJ
    HANNIGAN, GE
    MURTHY, AE
    GUSELLA, JF
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (06) : 645 - 650
  • [2] STRUCTURE AND EXPRESSION OF THE MURINE RETINOBLASTOMA GENE AND CHARACTERIZATION OF ITS ENCODED PROTEIN
    BERNARDS, R
    SCHACKLEFORD, GM
    GERBER, MR
    HOROWITZ, JM
    FRIEND, SH
    SCHARTL, M
    BOGENMANN, E
    RAPAPORT, JM
    MCGEE, T
    DRYJA, TP
    WEINBERG, RA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) : 6474 - 6478
  • [3] ISOLATION, CHARACTERIZATION, AND EXPRESSION OF THE MURINE WILMS-TUMOR GENE (WT1) DURING KIDNEY DEVELOPMENT
    BUCKLER, AJ
    PELLETIER, J
    HABER, DA
    GLASER, T
    HOUSMAN, DE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (03) : 1707 - 1712
  • [4] MUTATIONS IN THE BRCA1 GENE IN FAMILIES WITH EARLY-ONSET BREAST AND OVARIAN-CANCER
    CASTILLA, LH
    COUCH, FJ
    ERDOS, MR
    HOSKINS, KF
    CALZONE, K
    GARBER, JE
    BOYD, J
    LUBIN, MB
    DESHANO, ML
    BRODY, LC
    COLLINS, FS
    WEBER, BL
    [J]. NATURE GENETICS, 1994, 8 (04) : 387 - 391
  • [5] FRIEDMAN LS, 1995, NAT GENET, V8, P399
  • [6] BRCA1 MUTATIONS IN PRIMARY BREAST AND OVARIAN CARCINOMAS
    FUTREAL, PA
    LIU, QY
    SHATTUCKEIDENS, D
    COCHRAN, C
    HARSHMAN, K
    TAVTIGIAN, S
    BENNETT, LM
    HAUGENSTRANO, A
    SWENSEN, J
    MIKI, Y
    EDDINGTON, K
    MCCLURE, M
    FRYE, C
    WEAVERFELDHAUS, J
    DING, W
    GHOLAMI, Z
    SODERKVIST, P
    TERRY, L
    JHANWAR, S
    BERCHUCK, A
    IGLEHART, JD
    MARKS, J
    BALLINGER, DG
    BARRETT, JC
    SKOLNICK, MH
    KAMB, A
    WISEMAN, R
    [J]. SCIENCE, 1994, 266 (5182) : 120 - 122
  • [7] GAYTHER SA, 1995, IN PRESS NATURE GENE
  • [8] RAPID DETECTION OF BRCA1 MUTATIONS BY THE PROTEIN TRUNCATION TEST
    HOGERVORST, FBL
    CORNELIS, RS
    BOUT, M
    VANVLIET, M
    OOSTERWIJK, JC
    OLMER, R
    BAKKER, B
    KLIJN, JGM
    VASEN, HFA
    MEIJERSHEIJBOER, H
    MENKO, FH
    CORNELISSE, CJ
    DENDUNNEN, JT
    DEVILEE, P
    VANOMMEN, GJB
    [J]. NATURE GENETICS, 1995, 10 (02) : 208 - 212
  • [9] A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1
    MIKI, Y
    SWENSEN, J
    SHATTUCKEIDENS, D
    FUTREAL, PA
    HARSHMAN, K
    TAVTIGIAN, S
    LIU, QY
    COCHRAN, C
    BENNETT, LM
    DING, W
    BELL, R
    ROSENTHAL, J
    HUSSEY, C
    TRAN, T
    MCCLURE, M
    FRYE, C
    HATTIER, T
    PHELPS, R
    HAUGENSTRANO, A
    KATCHER, H
    YAKUMO, K
    GHOLAMI, Z
    SHAFFER, D
    STONE, S
    BAYER, S
    WRAY, C
    BOGDEN, R
    DAYANANTH, P
    WARD, J
    TONIN, P
    NAROD, S
    BRISTOW, PK
    NORRIS, FH
    HELVERING, L
    MORRISON, P
    ROSTECK, P
    LAI, M
    BARRETT, JC
    LEWIS, C
    NEUHAUSEN, S
    CANNONALBRIGHT, L
    GOLDGAR, D
    WISEMAN, R
    KAMB, A
    SKOLNICK, MH
    [J]. SCIENCE, 1994, 266 (5182) : 66 - 71
  • [10] A COLLABORATIVE SURVEY OF 80 MUTATIONS IN THE BRCA1 BREAST-CANCER AND OVARIAN-CANCER SUSCEPTIBILITY GENE - IMPLICATIONS FOR PRESYMPTOMATIC TESTING AND SCREENING
    SHATTUCKEIDENS, D
    MCCLURE, M
    SIMARD, J
    LABRIE, F
    NAROD, S
    COUCH, F
    HOSKINS, K
    WEBER, B
    CASTILLA, L
    ERDOS, M
    BRODY, L
    FRIEDMAN, L
    OSTERMEYER, E
    SZABO, C
    KING, MC
    JHANWAR, S
    OFFIT, K
    NORTON, L
    GILEWSKI, T
    LUBIN, M
    OSBORNE, M
    BLACK, D
    BOYD, M
    STEEL, M
    INGLES, S
    HAILE, R
    LINDBLOM, A
    OLSSON, H
    BORG, A
    BISHOP, DT
    SOLOMON, E
    RADICE, P
    SPATTI, G
    GAYTHER, S
    PONDER, B
    WARREN, W
    STRATTON, M
    LIU, QY
    FUJIMURA, F
    LEWIS, C
    SKOLNICK, MH
    GOLDGAR, DE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (07): : 535 - 541